No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Top-trader positions in RNAC could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.83 expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.46 / -$0.83Alpha Vantage | +$1.29 beat | $0.00 No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | -$0.95 / -$0.70Alpha Vantage | -35.71% miss | $78.0K No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Mar 9, 2026 | -$2.71 / -$0.79Alpha Vantage | -$1.92 miss | $2.8M No estimateYear ended Dec 31, 2025 · SEC filing | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$0.73 / -$0.63Alpha Vantage | -15.87% miss | $452.0K No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $0.50 / -$0.76Alpha Vantage | +$1.26 beat | $298.0K No estimateSEC filing | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$0.65 / -$0.71Alpha Vantage | +8.45% beat | $1.1M No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Mar 20, 2025 | -$0.59 / -$0.83Alpha Vantage | +28.12% beat | $38.9M No estimateYear ended Dec 31, 2024 · SEC filing | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | -$0.42 / -$0.55Alpha Vantage | +23.64% beat | $387.0K No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
This company is running thin margins.
Valuation
Quality
Growth
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace